Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLUCO-STAR
NCT05213988Unknown
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Jul 2018
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of bezafibrate in glucose metabolism disorder (4 arms), sponsored by Azienda Ospedaliero-Universitaria Pisana. Primary endpoint: Glucose tolerance at 180 minutes. Status: unknown.
02
Drugs
bezafibrate
03
Conditions
glucose metabolism disorder
Beyond the preview
Go deeper on NCT05213988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05213988.